Osteoarthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Osteoarthritis Pipeline Market Overview
Osteoarthritis pipeline market research report provides comprehensive information on the therapeutics under development for Osteoarthritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Osteoarthritis and features dormant and discontinued projects.
Key Targets in the Osteoarthritis Pipeline Market
The key targets in the Osteoarthritis pipeline market are Prostaglandin G/H Synthase 2, Prostaglandin G/H Synthase 1, Interleukin 1 Receptor, A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5, Collagenase 3, A Disintegrin And Metalloproteinase With Thrombospondin Motifs 4, and Angiopoietin Related Protein 3. Prostaglandin G/H Synthase 2 has the highest number of pipeline products.
Osteoarthritis Pipeline Market, by Targets
For more target insights, download a free report sample
Key MoA in the Osteoarthritis Pipeline Market
The key MoA in the Osteoarthritis pipeline market are Prostaglandin G/H Synthase 2 Inhibitor, Prostaglandin G/H Synthase 1 Inhibitor, Interleukin 1 Receptor Antagonist, A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 Inhibitor, Collagenase 3 Inhibitor, and A Disintegrin And Metalloproteinase With Thrombospondin Motifs 4 Inhibitor. Prostaglandin G/H Synthase 2 Inhibitor has the highest number of pipeline products.
Osteoarthritis Pipeline Market, by MoA
For more MoA insights, download a free report sample
Key RoA in the Osteoarthritis Pipeline Market
The key RoA in the Osteoarthritis pipeline market are intraarticular, oral, parenteral, intravenous, subcutaneous, intramuscular, and topical. Intraarticular has the highest number of pipeline products.
Osteoarthritis Pipeline Market, by RoA
For more RoA insights, download a free report sample
Key Molecule Types in the Osteoarthritis Pipeline Market
The key molecule types in the Osteoarthritis pipeline market are small molecule, cell therapy, biologic, fusion protein, gene therapy, and monoclonal antibody. Small molecule has the highest number of pipeline products.
Osteoarthritis Pipeline Market, by Molecule Types
For more molecule type insights, download a free report sample
Key Companies in the Osteoarthritis Pipeline Market
The key companies in the Osteoarthritis pipeline market are Novartis AG, LG Chem Ltd, Link Health Group, MediPost Co Ltd, biogen Pharma SpA, Achelios Therapeutics Inc, Atlanthera, and CarthroniX Inc. Novartis AG has the highest number of pipeline products.
Osteoarthritis Pipeline Market, by Companies
To know about more companies, download a free report sample
Market report overview
| Key targets | Prostaglandin G/H Synthase 2, Prostaglandin G/H Synthase 1, Interleukin 1 Receptor, A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5, Collagenase 3, A Disintegrin And Metalloproteinase With Thrombospondin Motifs 4, and Angiopoietin Related Protein 3 |
| Key MoA | Prostaglandin G/H Synthase 2 Inhibitor, Prostaglandin G/H Synthase 1 Inhibitor, Interleukin 1 Receptor Antagonist, A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 Inhibitor, Collagenase 3 Inhibitor, and A Disintegrin And Metalloproteinase With Thrombospondin Motifs 4 Inhibitor |
| Key RoA | Intraarticular, Oral, Parenteral, Intravenous, Subcutaneous, Intramuscular, and Topical |
| Key Molecule Types | Small Molecule, Cell Therapy, Biologic, Fusion Protein, Gene Therapy, and Monoclonal Antibody |
| Key Companies | Novartis AG, LG Chem Ltd, Link Health Group, MediPost Co Ltd, biogen Pharma SpA, Achelios Therapeutics Inc, Atlanthera, and CarthroniX Inc |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Osteoarthritis (Musculoskeletal Disorders).
- The pipeline guide reviews pipeline therapeutics for Osteoarthritis (Musculoskeletal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Osteoarthritis (Musculoskeletal Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Osteoarthritis (Musculoskeletal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Osteoarthritis (Musculoskeletal Disorders)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Osteoarthritis (Musculoskeletal Disorders).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Osteoarthritis (Musculoskeletal Disorders) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
4P-Pharma SAS
Abiogen Pharma SpA
Achelios Therapeutics Inc
Aclaris Therapeutics Inc
Adare Pharma Solutions
AfaSci Inc
Ageless Biotech Inc
Akaal Pharma Pty Ltd
Akan Biosciences LLC
AKL Research and Development Ltd
Algomedix Inc
Amgen Inc
Amplicore Inc
Amzell BV
Aprogen Inc
AskAt Inc
Asta Pharmaceuticals Co Ltd
Atlanthera
Aurealis Pharma AG
Axsome Therapeutics Inc
Bioiberica SAU
BioIntegrate Inc
BioNet Pharma GmbH
Bioorg3.14 LLC
Biosplice Therapeutics Inc
BioStem Technologies Inc
Bioventus Inc
BRIM Biotechnology Inc
Buzzz Pharmaceuticals Ltd
Caliway Biopharmaceutics Co Ltd
CAR-T (Shanghai) Biotechnology Co Ltd
Cartesian Therapeutics Inc
CarthroniX Inc
Cartilagen Inc
Causeway Therapeutics Ltd
Cellatoz Therapeutics Inc
Cellics Therapeutics Inc
CELLnLIFE Inc
Cells for Cells SA
CellTex Therapeutics Corp
Cellular Biomedicine Group Inc
Chondrogenix Ltd
Cmxtwenty
Cocoon Biotech, Inc.
Corestem Inc
CrystalGenomics Inc
Cynata Therapeutics Ltd
Cytonics Corp
Cytopeutics Pte Ltd
Daewoong Pharmaceutical Co Ltd
Dianomi Therapeutics Inc
DNX Biopharmaceuticals Inc
Dongkook Pharmaceutical Co Ltd
Eli Lilly and Co
Ensol Biosciences Inc
Enveric Biosciences Inc
Epione Therapeutics BV
Eternity Bioscience Inc
Evgen Pharma Plc
Exostemtech Co Ltd
Flexion Therapeutics Inc
Genascence Corp
Genequine Biotherapeutics GmbH
General Regeneratives Shanghai Ltd
General Therapeutics Inc
GlaxoSmithKline Plc
GPN Therapeutics Inc
Guangzhou Saliai Stemcell Science and Technology Co Ltd
Gwoxi Stem Cell Applied Technology Co Ltd
Haplnscience Inc
Hisamitsu Pharmaceutical Co Inc
Histogen Inc
Hope Biosciences LLC
Huaxia Source Cell Engineering Group Co Ltd
iCELL Biotechnology Co Ltd
ICM Co Ltd
Immetas Therapeutics Inc
ImmuneCyte Inc
ImmunoForge Co Ltd
Inception Therapeutics Inc
International Stem Cell Corp
Johnson & Johnson
Juniper Biologics Pte Ltd
Juvena Therapeutics Inc
Kaken Pharmaceutical Co Ltd
Kangstem Biotech Co Ltd
Kolon TissueGene Inc
Kukje Pharmaceutical Industry Co Ltd
Levolta Pharmaceuticals Inc
LG Chem Ltd
Likarda LLC
Link Biologics Ltd
Link Health Group
Lubris Biopharma
Luye Pharma Group Ltd
Magellan Biologicals Pty Ltd
MDimune Inc
Mecox Cure Med Co Ltd
Medicrinia Co Ltd
MediPost Co Ltd
Medivir AB
MeiraGTx Holdings Plc
Meluha Life Sciences Sdn Bhd
Merck KGaA
Meridigen Biotech Co Ltd
Mesoblast Ltd
MetrioPharm AG
MiMedx Group Inc
Mor Research Applications Ltd
Nanode Therapeutics Inc
NeuroBo Pharmaceuticals Inc
New York R&D Center for Translational Medicine and Therapeutics Inc
Nexbiome Therapeutics
Nordic Bioscience AS
Novartis AG
Novo Nordisk AS
Orbsen Therapeutics Ltd
Organicell Regenerative Medicine Inc
Organogenesis Holdings Inc
OrthoTrophix Inc
Oxacell AG
Paradigm Biopharmaceuticals Ltd
Paras Biopharmaceuticals Finland Oy
Parnia Stem Cell Knowledge-Based Co
Peptinov SAS
Personalized Stem Cells Inc
PersonGen BioTherapeutics (Suzhou) Co Ltd
Pfizer Inc
PhytoHealth Corp
Plakous Therapeutics Inc
PlateletBio
PMG PHARM Co Ltd
PrimeGen Global Inc
PrimRNA Inc
Progenitor Therapeutics Ltd
ProteoThera Inc
Regeneus Ltd
Regenosine Inc
Regulaxis SAS
Remedium Bio Inc
ReqMed Co Ltd
Ribomic Inc
Rottapharm Biotech Srl
Runjia (Suzhou) Pharmaceutical Technology Co Ltd
Sclnow Biotechnology Co Ltd
Seikagaku Corp
Serene LLC
Shandong Boan Biotechnology Co Ltd
Shionogi & Co Ltd
Simcere Pharmaceutical Group Ltd
SL Bigen Co Ltd
Steminent Biotherapeutics Inc
Stempeutics Research Pvt Ltd
Synartro AB
Synerkine Pharma BV
Synokem Pharmaceuticals Ltd
Taiwan Bio Therapeutics Co Ltd
Techfields Pharma Co Ltd
TheraBioPharma Inc
Traverse Biosciences Inc
Tremeau Pharmaceuticals Inc
Trialspark Inc
Turn Biotechnologies Inc
Unicocell Biomed Co Ltd
Vitro Diagnostics Inc
WEX Pharmaceuticals Inc
WNT Scientific LLC
Xalud Therapeutics Inc
Xintela AB
Yooyoung Pharm Co Ltd
Zhejiang Yatai Pharmaceutical Co Ltd
Zimmer Biomet Holdings Inc
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Osteoarthritis pipeline market?
The key targets in the Osteoarthritis pipeline market are Prostaglandin G/H Synthase 2, Prostaglandin G/H Synthase 1, Interleukin 1 Receptor, A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5, Collagenase 3, A Disintegrin And Metalloproteinase With Thrombospondin Motifs 4, and Angiopoietin Related Protein 3.
-
What are the key MoA in the Osteoarthritis pipeline market?
The key MoA in the Osteoarthritis pipeline market are Prostaglandin G/H Synthase 2 Inhibitor, Prostaglandin G/H Synthase 1 Inhibitor, Interleukin 1 Receptor Antagonist, A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 Inhibitor, Collagenase 3 Inhibitor, and A Disintegrin And Metalloproteinase With Thrombospondin Motifs 4 Inhibitor.
-
What are the key RoA in the Osteoarthritis pipeline market?
The key RoA in the Osteoarthritis pipeline market are intraarticular, oral, parenteral, intravenous, subcutaneous, intramuscular, and topical.
-
What are the key molecule types in the Osteoarthritis pipeline market?
The key molecule types in the Osteoarthritis pipeline market are small molecule, cell therapy, biologic, fusion protein, gene therapy, and monoclonal antibody.
-
What are the key companies in the Osteoarthritis pipeline market?
The key companies in the Osteoarthritis pipeline market are Novartis AG, LG Chem Ltd, Link Health Group, MediPost Co Ltd, biogen Pharma SpA, Achelios Therapeutics Inc, Atlanthera, and CarthroniX Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Musculoskeletal Disorders reports